Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q1 FY20 results · Apr–Jun 2019
Divi's Laboratories reported revenue from operations of ₹1,162.88 crore and net profit of ₹272.44 crore for Q1 FY20 (Apr–Jun 2019), on a consolidated basis.
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,162.88 | — | — | 0.00 | — |
| Other income | 30.32 | — | — | 0.00 | — |
| Total income | 1,193.20 | — | — | 0.00 | — |
| Profit before tax | 373.31 | — | — | 0.00 | — |
| Net profit for the period | 272.44 | — | — | 0.00 | — |
| EPS, basic (₹) | 10.26 | — | — | 0.00 | — |
| Net margin (%) | 23.4 | — | — |
| Item | Q1 FY20 | Q1 FY19 | YoY | Q4 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,139.92 | 995.31 | +14.5% | 1,256.43 | −9.3% |
| Other income | 31.63 | 48.79 | −35.2% | 41.73 | −24.2% |
| Total income | 1,171.55 | 1,044.10 | +12.2% | 1,298.16 | −9.8% |
| Profit before tax | 366.11 | 358.41 | +2.1% | 410.38 | −10.8% |
| Net profit for the period | 267.35 | 266.16 | +0.4% | 289.35 | −7.6% |
| EPS, basic (₹) | 10.07 | 10.03 | +0.4% | 10.90 | −7.6% |
| Net margin (%) | 23.5 | 26.7 | 23.0 |
Consolidated
- Filed with BSE
- 10 Aug 2019, 17:36 IST
- Board meeting
- 10 Aug 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Aug 2019, 17:36 IST
- Board meeting
- 10 Aug 2019
- Period
- 01 Apr 2019 to 30 Jun 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE